The Stocks in Action || How S&P/ASX200 Performed Ahead Of Fed’s Two-Day Meeting?

Hi, you are watching Kalkine TV live from Sydney. This is The Stocks in Action show. First, let's look at ASX 200 and then we will discuss the ASX listed stocks that are trending today.  

• The S&P/ASX200 is up today, gaining 12.70 points or 0.17 per cent to 7392.20 and setting a new 52-week high. The top performing stocks in this index are SEEK up 3.20 per cent  and WOODSIDE PETROLEUM, up 2.99 per cent.

• The Dow Jones fell 0.27 per cent to 34,299.33, while the S&P 500 lost 0.2 per cent to 4,246.5. The NASDAQ Composite was down 0.71 per cent, to 14,072.86. 

• Nyrada Inc. (ASX:NYR) has reported new lead drug candidate NYR-BI01 has advanced to efficacy studies in collaboration with the Walter Reed Army Institute of Research (WRAIR).  

• Rhythm Biosciences Limited (ASX:RHY) has confirmed that Rhythm’s ColoSTAT® clinical trial is being joined by Sonic Clinical Services.  

• The Board of AF Legal Group Ltd (ASX:AFL) has announced that it has now completed its acquisition of Watts McCray (NSW) Pty Ltd, one of Australia’s leading family law firms. 

• Archer Exploration Limited (ASX:AXE) shared that it will be collaborating with The Australian Missile Corporation (AMC) to support Australia’s Sovereign Guided Weapons Enterprise. 

• AMC is a division of NIOA. It is Australia-based Defence Prime Contractor and supplier of weapons and munitions to the Defence division of Australia. 

• Avita Medical (ASX:AVH) upgraded its revenue forecasts for fiscal quarter four guidance to between $9.5 million to $9.7 million

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.



Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK